Information Technology and Business Intelligence

Question: Discuss about theInformation Technology and Business Intelligence. Answer: Introduction The use of business Intelligence techniques has accelerated pharmaceutical company. The Pharmaceutical companies are evaluating the models that are related with business and thus it helps in focusing on the business Intelligence tools (Smith, 2016). The report helps in unearthing the nature and role of business Intelligence, role of information technology in business intelligence, key issues and roles of information technology in Pharmaceutical Company. Discussion Nature and Role of Business Intelligence According to Betz and Tidona (2015), pharmaceutical companies are implementing business Intelligence technologies for their drug development process. The companies have deployed and purchased the different technology solutions for automating and standardizing workflows. The pharmaceutical companies are very much mature in terms of business intelligence though a large number of vendors have successfully pierced the market by selling solutions to Biotech ad Big Pharma. On the other hand, de Carvalho and Sassi (2014 ) argued that the present competitive landscape related with the business intelligence vendor are diverse. It consists of organization that has different market portfolios, technologies and market approaches. Some vendors helps in providing horizontal Business Intelligence tools for analysing, integrating and measuring the performance of data where as other vendors have offered different developmental environments for the organizations in order to build applications that are required for unique need (Du et al., 2016). Furthermore, there are vendors who help in supplying a full suite of business intelligence tools while the other organizations are specialized in one or more technological areas such as predictive and reporting analytics. According to Smith (2016), the key business intelligence vendor which helps in serving the customers of the Biotech and Big Pharma includes GenoLogics, Genstruct, SAS and Oracle. The vendors are selected in order to provide a sample of Business Intelligence vendors in terms of technologies that are offered, size and market focus (Elizabeth et al., 2016). Each of the vendors was evaluated on the basis of a framework that is known as market readiness. A score was used by each of the users for the pharmaceutical users in order to specify business intelligence solutions for their partnership strategy and for supporting the capabilities. The three important pharmaceutical companies in USA include Johnson Johnson, Gilead Sciences and Pfizer. The companies are operating in order to conduct various research and for collecting huge amount of data. According to Tanev and Kleismantas (2015), the pharmaceutical industries of USA value business intelligence products which are scalable across various departments and thus help other organizations in creating global protocol and streamlined workflows. Business intelligence equipment must help in reflecting the domain expertise and thus creating or making sense in the hands of end-users. The challenges for different vendors include offering various business class BI solutions for transitional medicine and for keeping the cost that is associated with the medicine and professional. Information Technology in Pharmaceutical Companies Needs of Information Technology According to Smith (2016), the pharmaceutical industries are using both the outsourcing as well as off-shoring of IT work which includes maintenance of vendor companies and application development. With the help of outsourcing, pharmaceutical organizations are getting substantial savings in the areas of business which includes management of clinical data support of IT infrastructure, drug discovery that is IT enabled scientific communications and may more. On the other hand, Rastogi et al. (2015) argued that benefits that are collected from cost savings which is known as labour arbitrage. The companies expect that the resources must focus on the operations of the business that are fully innovative in nature by having IT vendors as the perfect guide. Evaluation of Key Issues According to Smith (2016) there are various key issues that are associated with the Information system of Pharmaceuticals Company. IT breach is one of the issues that lead to theft of identity, counterfeit drugs and loss of revenue. On the other hand, Betz andTidona (2015) stated that routine procedure is related with security that can fall short in securing the data of the IT system of a pharmaceutical company. It raises lot of issues which includes security and privacy concerns, violation of data and many more. Blueblugging is one of the issue or challenge that helps in attacking the phone of the victim. Bluejacking is another issue, due to which the privacy of the users get lost as they enforce long messages into the phone of the victim without having their permission. Tasks and Roles in an Information Technology Environment for Successful Pharmaceutical Business According to Tanev and Kleismantas (2015), pharmaceutical companies expect that all their vendors are achieving their regulatory compliance at a very low cost. The efficient and cost-effective services that meet the requirements of regulatory compliance are the key vendors for the external service providers in order to contract more number of companies. On the other hand, Elizabeth et al. (2016) stated that IT vendors must view the regulatory compliance for proper management, execution as well as for delivering proper IT business solutions. The pharmaceutical organizations are selecting IT vendors on the basis of different credentials in the compliance services for focussing on the capability and experience in the areas of compliance which includes data privacy, qualification and management of validation. On the other hand, Rastogi et al. (2015) stated that oracle and SAS influence their expertise for the applications that are related with the enterprises and analytics in order to gain industry based solutions in the market. Additionally horizontal vendors support or influence the strength of the brand in the pharmaceutical industry. Conclusion It is concluded that both the business intelligence technique as well as information system are significant for the development of Pharmaceutical companies. It is analyzed that some vendors helps in providing horizontal Business Intelligence tools for analysing, integrating and measuring the performance of data whereas with the help of outsourcing, medicinal groups are getting considerable investments in the areas of business. The companies expect that the resources must focus on the processes of the business that are fully advanced in nature by having IT dealers as the perfect guide. References Betz, U. A., Tidona, C. A. (2015). Outcubation [mdash] where incubation meets outsourcing.Nature biotechnology,33(1), 20-21. de Carvalho, T. V., Sassi, R. J. (2014). An alternative to face worldwide financial crisis of 2008: best practices usage of a business intelligence architecture in a chemical industry.International Journal of Business Innovation and Research,8(4), 399-410. Du, M., Pivovarova, L., Yangarber, R. (2016, July). PULS: natural language processing for business intelligence. InProceedings of the 2016 Workshop on Human Language Technology(p. 1). Go to Print Publisher. Elizabeth H, R. John C. Yi,, S. (2016). Retrieved 21 September 2016, from https://file:///D:/new..ppt/969341_1518617304_AnalyzingtheEffectivenessof.pdf Rastogi, S., Singh, A. P., Virmani, T. (2015). Knowledge Processing Outsourcing (Kpo): Opportunities In Pharmacy Research And Development.Indian Journal of Drugs,3(3), 71-78. Smith, N. C. (2016). From Corporate Philanthropy to Creating Shared Value: Big Pharmas New Business Models in Developing Markets.GfK Marketing Intelligence Review,8(1), 30-35. Tanev, S., Liotta, G., Kleismantas, A. (2015). A business intelligence approach using web search tools and online data reduction techniques to examine the value of product-enabled services.Expert Systems with Applications,42(21), 7582-7600. Thomas, S. (2016). Retrieved 21 September 2016, from https://file:///D:/new..ppt/969343_1471105397_Sept-201420-Year-TrendsThomas-.pdf